✦ LIBER ✦

E.O.R.T.C. protocol for the treatment of good-risk patients with chronic myelogenous leukemia. A randomized trial

✍ Scribed by C. Haanen; K.-P. Hellriegel; D. Machin

Book ID: 113146308
Publisher: Elsevier Science
Year: 1979
Weight: 499 KB
Volume: 15
Category: Article
ISSN: 0014-2964
DOI: 10.1016/0014-2964(79)90157-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

E.O.R.T.C. protocol for the therapy of m

E.O.R.T.C. protocol for the therapy of metastatic soft tissue sarcoma, a randomized trial

✍ H.M. Pinedo; C.P.J. Vendrik; M. Staquet; Y. Kenis; R. Sylvester 📂 Article 📅 1977 🏛 Elsevier Science ⚖ 540 KB

Effects of vitamin a on survival in pati

Effects of vitamin a on survival in patients with chronic myelogenous leukemia: A SWOG randomized trial

✍ Frank L. Meyskens Jr; Kenneth J. Kopecky; Frederick R. Appelbaum; Stanley P. Bal 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 940 KB

Anagrelide for Treatment of Patients wit

Anagrelide for Treatment of Patients with Chronic Myelogenous Leukemia and a High Platelet Count

✍ Oliver M Trapp; Maria K Beykirch; Petro E Petrides 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 70 KB

A long term follow-up of a randomized tr

A long term follow-up of a randomized trial comparing interferon-α with busulfan for chronic myelogenous leukemia

✍ K. Ohnishi; M. Tomonaga; N. Kamada; K. Onozawa; A. Kuramoto; H. Dohy; H. Mizoguc 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 100 KB

Treatment of polycythaemia vera by radio

Treatment of polycythaemia vera by radiophosphorus or busulphan: A randomized trial. “Leukemia and Hematosarcoma” Cooperative Group, European Organization for Research on Treatment of Cancer (E.O.R.T.C.)

📂 Article 📅 1981 🏛 Nature Publishing Group 🌐 English ⚖ 778 KB

Thiotepa for the treatment of thrombocyt

Thiotepa for the treatment of thrombocythemia in patients with Philadelphia chromosome positive chronic myelogenous leukemia

✍ Edgardo J. Rodriguez-Monge; Jorge E. Cortes; Susan O'Brien; Moshe Talpaz; Hagop 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 3 views

## Background: Patients with chronic myelogenous leukemia (cml) occasionally experience persistent thrombocythemia despite having adequate white blood cell (wbc) counts. trimethylenethiophosphoramide (thiotepa) is an alkylating agent that significantly inhibits platelet production. ## Methods: Th